Boston Millennia Partners

Our Firm

Our Team

Our Portfolio

	• Healthcare IT and Business Services

	• Life Sciences

	• Other Investment Successes

Investment Performance

Resources

News



	Josef von Rickenbach from PAREXEL International Corporation on Boston Millennia Partners...

< Home < Our Portfolio < Testimonials < Our Portfolio

Boston Millennia Partners’ portfolio reflects Millennia’s commitment towards building enduring, large-scale businesses that have the potential to provide superior financial returns to our investors. Millennia’s portfolio is comprised of a diversified group of firms each positioned with the potential to become leaders in their respective market segments. We invite you to use the links below to learn more about each of those portfolio companies.

< Back

  108 T. W. Alexander Drive
  PO Box 110347
  Research Triangle Park, NC 27709

Phone: (919) 328-4100
Fax: (919) 328-4101

Athenix Corp. is a privately held biotechnology company developing innovative, high-value, bio-industrial products for the Agricultural and Chemical businesses using genetic traits from microbes. These traits are used to develop enhanced plants, microbes, enzymes, and processes capable of providing renewable resources for a variety of industry sectors. Athenix is focused on two major market opportunities: 1) the discovery of genes and proteins for novel input traits (such as insect resistance, nematode resistance and herbicide tolerance), and their use to develop transgenic plants for the Agricultural Chemical and Seed Industries; and 2) the discovery of genes and proteins for improved bioconversion in the Chemical, Alternative Energy and Animal Feed Industries.

Millennia Team	Rob Jevon, Brad Callow

Visit the Website	http://www.athenixcorp.com/

Related News	Boston, MA - November 4, 2009 Portfolio Company Athenix Sold for $400 Million to Bayer, a 10X return to BMP Monheim, Germany - November 2, 2009 Bayer CropScience Completes $400 Million Acquisition of Biotech Company Athenix Corp. Des Moines, IA - January 15, 2009 DuPont and Athenix Collaborate to Advance Insect Control in Corn, Soybeans Johnston, Iowa - May 19, 2008 Iowa Corn Checkoff Collaborates With Biotech Firm Athenix to Develop Nitrogen-Efficient Hybrids Research Triangle Park, N.C. - January 31, 2008 Athenix and Syngenta in R&D Partnership for Advanced Biotechnology Corn Insect and Soybean Nematode Control Traits Research Triangle Park, North Carolina and St. Louis, MO – August 20th, 2007 New Glyphosate-Tolerant Corn From Athenix Demonstrates Superior Performance Research Triangle Park, North Carolina and St. Louis, MO – June 20th, 2007 Athenix and Monsanto Announce Collaboration on Research for Insect Control Research Triangle Park, North Carolina - December 12, 2006 Athenix presents poster at 2006 Annual Meeting of the Entomological Society of America: Novel Insecticidal Proteins Research Triangle Park, North Carolina - November 30, 2006 Athenix traits for insect resistance and herbicide tolerance display excellent field performance. Research Triangle Park, North Carolina – January 6, 2006 Athenix secures $13 Million in Series C Financing Research Triangle Park, North Carolina - October 5, 2005 Athenix reports successful field trials with novel genes providing high-level tolerance to the herbicide glyphosate Research Triangle Park, NC -- February 17, 2005 Athenix and Iowa Corn Promotion Board Announce Research Cooperation Research Triangle Park, NC -- January 20, 2004 Athenix secures $12.5 Million in Series B Financing Research Triangle Park, NC -- September 10, 2001 Athenix Secures $8 Million in Venture Capital

Our Firm Our Team Our Portfolio Resources News